Chronic lymphocytic leukemia (CLL) is a complex and heterogeneous disease characterized by the proliferation and accumulation of CD5+ B cells in peripheral blood (PB), bone marrow (BM), and lymphoid tissues [1, 2]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.